Home Corporate Oil & Gas Solar Energy Life Sciences News Investors QwikReport Italy & Greece Solar Flow Through Solar News Subscribe for Updates There are no "Italy & Greece" items released on this web site at this time. HomeCorporateOil & GasSolar EnergyLife SciencesNewsInvestorsQwikReport ©2012 Berkley Renewables Inc. | Disclaimer

Home Corporate Oil & Gas Solar Energy Life Sciences News Investors QwikReport About Us From the CEO In the News Latest Newsletter Our Team Corporate Directory Contact Us Subscribe for Updates March 24, 2015 Our solar and life science interests are making significant headway in the first quarter of 2015. Solar Flow-Through Solar Flow-Through recently announced it's proceeding with construction on its FIT 2 solar PV projects in Ontario. Panasonic Eco Solutions Canada Inc. is engineering and constructing a large majority of these projects. Nearly all the FIT 2 projects are expected to be complete by the end of Q2 2015. Solar Flow-Through is also participating in more than 100 FIT 3 and FIT 3.5 solar PV contracts with its development partners. The Ontario Power Authority is expected to announce FIT 3.5 contracts awards by the end of Q1 2015. All the FIT 3.5 projects are expected to be completed and operating by the end of Q3 2016. Dividend payments for the 2012-I Limited Partnership are continuing in 2015 and dividends for the 2013-I Limited Partnership are expected to begin at the end of Q3 2015. RepliCel Life Sciences RepliCel's management and R&D teams were in Japan for key industry meetings in March. On March 20th, RepliCel's Chief Medical Officer, Dr. Rolf Hoffmann, presented at the 14th Congress of the Japanese Society of Regenerative Medicine alongside representatives from the R&D team of the company's licensing partner Shisiedo Company Ltd. The speakers shared RepliCel's clinical studies for the treatment of pattern baldness with cell-based regenerative therapy. On March 24, RepliCel's CEO David Hall presented at the 12th Annual BioAsia International Conference in Tokyo. Mr. Hall spoke about the company's platform technologies, clinical activities and its active partnership with Japan-based Shisiedo. RepliCel management and R&D teams were also in Japan to conduct private meetings with the Japanese Pharmaceutical and Medical Devices Agency, strategic partners and potential investors. I'm looking forward to sharing more exciting news from both of these companies in the coming weeks and months. Matt Wayrynen, President & CEO Berkley Renewables, Inc. View Archive HomeCorporateOil & GasSolar EnergyLife SciencesNewsInvestorsQwikReport ©2012 Berkley Renewables Inc. | Disclaimer

Home Corporate Oil & Gas Solar Energy Life Sciences News Investors QwikReport Subscribe for Updates There are no "Disclaimer" items released on this web site at this time. HomeCorporateOil & GasSolar EnergyLife SciencesNewsInvestorsQwikReport ©2012 Berkley Renewables Inc. | Disclaimer